Weekly Dry Ice with Delivery and Cylinder Charges to Rocky Mountain Labs in Hamilton, Montana
ID: RFQ-NIAID-25-2246875Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

Industrial Gas Manufacturing (325120)

PSC

CHEMICALS (6810)
Timeline
    Description

    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking qualified vendors to provide weekly deliveries of dry ice pellets, totaling approximately 400 pounds per week, to the Rocky Mountain Labs in Hamilton, Montana. The procurement aims to support scientific experiments and the shipping of biological materials, with a contract period from December 1, 2024, to November 30, 2025, and an additional allocation of 3,000 pounds for contingencies during high-demand periods. Interested vendors must submit their quotes by November 6, 2024, and are encouraged to contact Dana Monroe at dana.monroe@nih.gov for further inquiries. The contract will be awarded based on technical capability and price, with a firm fixed price purchase order anticipated.

    Point(s) of Contact
    Files
    Title
    Posted
    This document outlines a government request for proposals (RFP) concerning the procurement of dry ice pellets, totaling 23,800 lbs, for a one-year period from December 1, 2024, to November 30, 2025. The specification requires a weekly delivery of 400 lbs, with an additional 3,000 lbs allocated for contingencies during high-demand periods. Vendors are asked to factor in hazardous material and cylinder delivery charges calculated per week over the contract duration. Deliveries are scheduled for Wednesdays, with requests made the prior Friday based on the needs of the RML. Vendors must accommodate potential emergency orders at agreed unit pricing, with necessary funding included in the purchase order. The document stresses adherence to industry standards for pellet specifications and mandates billing to occur in arrears, indicating a deliberate and structured approach to procurement and supply chain management to ensure compliance and operational readiness.
    The document outlines two clauses relevant to government contracts: the "Option for Increased Quantity" and the "Option to Extend the Term of the Contract." The first clause (FAR 52.217-6) allows the government to increase the quantity of supplies specified in the contract at the unit price set forth, provided that the Contracting Officer notifies the Contractor within 30 days. The added items must be delivered at the same rate as the original items unless otherwise negotiated between the parties. The second clause (FAR 52.217-9) permits the government to extend the contract's duration through a written notice to the Contractor within 12 months of the initial contract's expiration. Additionally, the government must provide at least 60 days' notice of this intent, with the extended contract duration capped at 3 years in total, including any exercised options. These clauses are critical as they provide flexibility for government agencies to adjust contract terms according to operational needs, ensuring that contractors are informed and that projects can be sustained without interruption.
    The document outlines the Federal Acquisition Regulation (FAR) clause 52.212-5, which mandates compliance with various statutory and executive order requirements for contractors involved in acquisitions of commercial products and services. It details mandatory clauses that contractors must adhere to, including prohibitions on confidentiality agreements, restrictions on contracting with certain foreign entities, and requirements for promoting small business participation. The contractor must also comply with record retention provisions for audit purposes. Although some clauses must flow down to subcontractors, others are not required. This comprehensive framework ensures that federal contracting promotes ethical practices, supports small businesses, and complies with legal standards while facilitating transparency and accountability in government contracts. The document's purpose aligns with federal RFPs and grants, emphasizing regulatory compliance and ethical standards in government procurement processes.
    Lifecycle
    Title
    Type
    Similar Opportunities
    COMPREHENSIVE FIVE YEAR SERVICE PACKAGE - ENVIRONMENTAL MONITORING SYSTEM SERVICE (AMBIS 2203139)
    Active
    Health And Human Services, Department Of
    Presolicitation Notice: Department of Health and Human Services, Department of National Institutes of Health (NIH) intends to negotiate with Rees Scientific for the procurement of an environmental monitoring system package. The package includes a comprehensive five-year service package with various components and documentation. The service shall be performed at Rocky Mountain Laboratories (RML) in Hamilton, MT. The monitoring system is required to ensure compliance with regulations enforced by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) for animal research operations at RML. This is a sole source requirement, and no other company has the authority to perform these critical services. Interested parties may submit a capability statement for consideration by the Government.
    CYTEK AURORA 5 LASER WITH LOADER - UV/V/B/YG/R - PREMIUM SERVICE AGREEMENT
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for a premium service agreement for a Cytek Aurora 5 laser with loader, which is essential for advanced laboratory applications. The procurement includes comprehensive maintenance services, such as preventive inspections, technical support, and on-site assistance, ensuring optimal functionality of the equipment throughout the contract period from December 1, 2024, to November 20, 2025. This acquisition is critical for supporting the NIH's research initiatives in allergy and infectious diseases, emphasizing the importance of reliable laboratory equipment and services. Interested vendors must submit their quotations via the NIAID electronic Simplified Acquisition Submission System (eSASS) by November 13, 2024, at 12:00 am EST, and can contact Maliaka Pinkney or Jesse D Weidow for further inquiries.
    Relocation of Sartorius CompacT SelecT (Annapurna) for decommissioning, and relocation of CompacT SelecT (Quartz) to NCATS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is seeking a qualified vendor to facilitate the relocation and decommissioning of two Sartorius CompacT SelecT systems, specifically the Annapurna and Quartz models, as part of a sole source contract with Sartorius Stedim North America Inc. The project involves two phases: first, disassembling the Annapurna system for storage at the National Center for Advancing Translational Sciences (NCATS), and second, preparing the Quartz system for disassembly, transport, and recommissioning at NCATS. This procurement is critical for ensuring the safe transfer and management of specialized scientific equipment essential for NIH's medical research initiatives. Interested parties must submit their capabilities and proposals by November 6, 2024, to Patricia da Silva at patricia.dasilva@nih.gov, with the contract expected to commence in February 2025.
    CYTEK AURORA 5 LASER PREMIUM SERVICE AGREEMENT
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified contractors to provide a premium service agreement for the Cytek Aurora 5 Laser systems. The procurement includes essential services such as preventive maintenance inspections, technical support, and on-site assistance for four specific Cytek Aurora 5 Laser units, ensuring optimal performance and reliability during the contract period from March 1, 2025, to February 28, 2026. This service agreement is critical for maintaining the functionality of laboratory equipment used in vital research, reflecting the NIH's commitment to supporting scientific advancements. Interested vendors must submit their quotations via the NIAID electronic Simplified Acquisition Submission System (eSASS) by November 12, 2024, at 12:00 am EST, and can contact Maliaka Pinkney at maliaka.pinkney@nih.gov for further inquiries.
    Bulk Liquid Nitrogen
    Active
    Agriculture, Department Of
    The U.S. Department of Agriculture (USDA), through the Animal and Plant Health Inspection Service (APHIS), is soliciting quotes for an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to supply bulk liquid nitrogen from January 1, 2025, to December 31, 2029. The contract requires an estimated annual supply of 54,000 gallons of bulk liquid nitrogen that must meet specific standards outlined in the solicitation, with delivery to a USDA facility in Ames, Iowa. This procurement is critical for maintaining operational efficiency in agricultural research and health inspections, emphasizing the importance of reliable nitrogen supply and remote monitoring of the nitrogen tank levels. Interested small business concerns must submit their quotes, including a cover sheet and completed SF 1449 form, by the specified deadlines, and inquiries should be directed to the primary contact, Connor Tees, at stephen.tees@usda.gov, with a deadline for questions set for November 1, 2024.
    Sources Sought Rees Scientific Environmental Monitoring Maintenance Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking qualified contractors to provide validation, calibration, and preventative maintenance services for the Rees Scientific Environmental Monitoring/Alarm System at the Clinical Center's Center for Cellular Engineering in Bethesda, Maryland. The contractor will be responsible for ensuring compliance with regulatory standards by monitoring critical environmental parameters such as temperature, humidity, and gas levels in facilities that manufacture cell and gene therapies for clinical trials. This initiative is crucial for maintaining high standards in clinical research environments and ensuring the integrity of sensitive biological materials. Interested parties must submit their responses by email to Sheri Eiri at sheri.eiri@nih.gov by 12:00 PM EST on November 7, 2024, and must be registered in the System for Award Management (SAM) to be eligible for consideration.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the "Preparation and Distribution of Research Drug Products" under solicitation number 75N95024R00003. The primary objective of this procurement is to acquire, analyze, create, and distribute a variety of drug compounds essential for drug abuse and addiction research, including controlled and uncontrolled substances, while ensuring compliance with DEA regulations. This contract, structured as an indefinite delivery, indefinite quantity (IDIQ) agreement for a five-year period, aims to enhance research capabilities in the field of drug abuse, with proposals due by November 15, 2024, at 1:00 PM (Eastern Time). Interested parties should contact Scott Duernberger at scott.duernberger@nih.gov or Josh Lazarus at josh.lazarus@nih.gov for further information.
    Notice of Intent to Sole Source; Monument Medical
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to QuVA Pharma, Inc. for the procurement of compounded intravenous (IV) narcotics for patient care at the NIH Clinical Center. This acquisition aims to secure sterile compounded products that meet the quality standards necessary for ongoing patient treatment, as QuVA Pharma is the sole distributor of these specific IV narcotics in the U.S. market. Interested parties are invited to express their interest and capabilities regarding this procurement, with comments due by November 15, 2024, at 10 AM EST, directed to Kristin Nagashima at kristin.nagashima@nih.gov.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Control (CMC) services related to the development of drug substances under RFP number 75N95024R00094. The primary objective is to secure high-quality drug substances to support preclinical and Investigational New Drug (IND)-enabling studies, ensuring compliance with current Good Manufacturing Practices (cGMP) and federal regulations. This initiative is crucial for advancing therapeutic innovations and facilitating collaborations in drug development, with a total funding amount of up to $49.7 million over the contract period from September 1, 2025, to May 14, 2031. Interested parties must submit their proposals by December 3, 2024, and can direct inquiries to primary contact Samson Shifaraw at samson.shifaraw@nih.gov or secondary contact Valerie Whipple at valerie.whipple@nih.gov.
    BD Biosciences Proprietary Instrumentation Package and Reagent Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure a proprietary instrumentation package and reagent kits from Becton, Dickinson & Company for the Department of Laboratory Medicine. This acquisition aims to secure essential supplies, including instrument rentals and quality control materials, necessary for the operation of the Hematology Flow Cytometry Service, which plays a critical role in patient care and research. The procurement is vital for maintaining the laboratory's capacity to deliver timely and accurate results, as the specified reagent kits are uniquely compatible with the existing BD Rhapsody™ single cell analysis system. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 14, 2024, at 6:30 AM EST, as this is a presolicitation notice and not a request for quotations.